{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:13:42Z","timestamp":1790748822860,"version":"4.1.0"},"reference-count":176,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.bone.2017.09.008","type":"journal-article","created":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T07:16:45Z","timestamp":1505805405000},"page":"276-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":251,"special_numbering":"C","title":["A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease"],"prefix":"10.1016","volume":"105","author":[{"given":"Eric","family":"Marty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.09.008_bb0005","series-title":"Population Division","article-title":"Projections of the Population by Selected Age Groups and Sex for the United States: 2010 to 2050 (NP2008-T2)","author":"Table 2","year":"2008"},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0010","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ageing\/afs197","article-title":"Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS)","volume":"42","author":"Patel","year":"2013","journal-title":"Age Ageing"},{"issue":"5 Suppl","key":"10.1016\/j.bone.2017.09.008_bb0015","first-page":"1121","volume":"50","year":"1989","journal-title":"Am. J. Clin. Nutr."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11914-014-0204-5","article-title":"Therapies for musculoskeletal disease: can we treat two birds with one stone?","volume":"12","author":"Girgis","year":"2014","journal-title":"Curr. Osteoporos. Rep."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0025","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/00005768-200005000-00006","article-title":"Muscle, bone, and the Utah paradigm: a 1999 overview","volume":"32","author":"Frost","year":"2000","journal-title":"Med. Sci. Sports Exerc."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0030","first-page":"185","article-title":"The Utah paradigm on animal models of skeletal disorders: quo vadis?","volume":"1","author":"Frost","year":"2001","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0035","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/jbmr.1972","article-title":"Muscle size, strength, and physical performance and their associations with bone structure in the Hertfordshire Cohort Study","volume":"28","author":"Edwards","year":"2013","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0040","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00774-013-0443-z","article-title":"Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis","volume":"31","author":"Miyakoshi","year":"2013","journal-title":"J. Bone Miner. Metab."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0045","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4082\/kjfm.2013.34.4.281","article-title":"Association between sarcopenia, bone density, and health-related quality of life in Korean men","volume":"34","author":"Go","year":"2013","journal-title":"Korean J. Fam. Med."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.maturitas.2013.03.016","article-title":"Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia","volume":"75","author":"Sjoblom","year":"2013","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jocd.2008.10.003","article-title":"Fat-free mass, strength, and sarcopenia are related to bone mineral density in older women","volume":"12","author":"Lima","year":"2009","journal-title":"J. Clin. Densitom."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0060","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00198-012-2057-z","article-title":"Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men","volume":"24","author":"Verschueren","year":"2013","journal-title":"Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0065","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.archger.2012.05.002","article-title":"Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients","volume":"55","author":"Di Monaco","year":"2012","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0070","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.archger.2010.02.002","article-title":"Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture","volume":"52","author":"Di Monaco","year":"2011","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2017.09.008_bb0075","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1007\/s40520-013-0102-1","article-title":"Sarcopenia in women with vertebral fragility fractures","volume":"25","author":"Iolascon","year":"2013","journal-title":"Aging Clin. Exp. Res."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0080","first-page":"707","article-title":"Fall risk and fracture. Diagnosing sarcopenia and sarcopenic leg to prevent fall and fracture: its difficulty and pit falls","volume":"23","author":"Hida","year":"2013","journal-title":"Clin. Calcium"},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0085","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1007\/s00586-015-3805-5","article-title":"Sarcopenia and sarcopenic leg as potential risk factors for acute osteoporotic vertebral fracture among older women","volume":"25","author":"Hida","year":"2016","journal-title":"Eur. Spine J."},{"issue":"8","key":"10.1016\/j.bone.2017.09.008_bb0090","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jamda.2014.02.005","article-title":"Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: results from the Osteoporotic Fractures in Men (MrOs) Study","volume":"15","author":"Yu","year":"2014","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0095","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/BOR.0b013e328358d59b","article-title":"Sarcopenia in older adults","volume":"24","author":"Walston","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"issue":"Suppl. 2","key":"10.1016\/j.bone.2017.09.008_bb0100","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1123\/jpah.8.s2.s161","article-title":"Physical activity of urban community-dwelling older Latino adults","volume":"8","author":"Marquez","year":"2011","journal-title":"J. Phys. Act. Health"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0105","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.clnu.2009.09.003","article-title":"Older adults and patients in need of nutritional support: review of current treatment options and factors influencing nutritional intake","volume":"29","author":"Nieuwenhuizen","year":"2010","journal-title":"Clin. Nutr."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcn\/87.1.150","article-title":"Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study","volume":"87","author":"Houston","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0115","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","article-title":"Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014","volume":"5","author":"Morley","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0047-6374(98)00130-4","article-title":"Predictors of skeletal muscle mass in elderly men and women","volume":"107","author":"Baumgartner","year":"1999","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ageing\/29.3.235","article-title":"Relationships between physical performance measures, age, height and body weight in healthy adults","volume":"29","author":"Samson","year":"2000","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/JES.0b013e3181d496bc","article-title":"Mechanisms behind estrogen's beneficial effect on muscle strength in females","volume":"38","author":"Lowe","year":"2010","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1677\/JOE-09-0431","article-title":"The GH\/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis","volume":"205","author":"Perrini","year":"2010","journal-title":"J. Endocrinol."},{"issue":"7","key":"10.1016\/j.bone.2017.09.008_bb0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0047-6374(03)00124-6","article-title":"Age-related differences in the des IGF-I-mediated activation of Akt-1 and p70 S6K in mouse skeletal muscle","volume":"124","author":"Li","year":"2003","journal-title":"Mech. Ageing Dev."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1152\/physiolgenomics.00191.2007","article-title":"Aging alters gene expression of growth and remodeling factors in human skeletal muscle both at rest and in response to acute resistance exercise","volume":"32","author":"Dennis","year":"2008","journal-title":"Physiol. Genomics"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0150","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/ijms11041509","article-title":"Oxidative stress, molecular inflammation and sarcopenia","volume":"11","author":"Meng","year":"2010","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11357-010-9159-3","article-title":"How pleiotropic genetics of the musculoskeletal system can inform genomics and phenomics of aging","volume":"33","author":"Karasik","year":"2011","journal-title":"Age (Dordr.)"},{"issue":"10","key":"10.1016\/j.bone.2017.09.008_bb0160","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"6628","key":"10.1016\/j.bone.2017.09.008_bb0165","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0170","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/jcp.20778","article-title":"Prolonged absence of myostatin reduces sarcopenia","volume":"209","author":"Siriett","year":"2006","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0175","first-page":"343","article-title":"Serum myostatin-immunoreactive protein is increased in 60\u201392year old women and men with muscle wasting","volume":"6","author":"Yarasheski","year":"2002","journal-title":"J. Nutr. Health Aging"},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.exger.2013.02.012","article-title":"The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size","volume":"48","author":"Nilwik","year":"2013","journal-title":"Exp. Gerontol."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00198-009-1059-y","article-title":"Sarcopenia: etiology, clinical consequences, intervention, and assessment","volume":"21","author":"Lang","year":"2010","journal-title":"Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.1215","article-title":"Aging of the human neuromuscular system","volume":"25","author":"Vandervoort","year":"2002","journal-title":"Muscle Nerve"},{"issue":"2\u20133","key":"10.1016\/j.bone.2017.09.008_bb0195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s00421-005-1390-8","article-title":"Quadriceps maximal power and optimal shortening velocity in 335 men aged 23\u201388years","volume":"95","author":"Kostka","year":"2005","journal-title":"Eur. J. Appl. Physiol."},{"key":"10.1016\/j.bone.2017.09.008_bb0200","article-title":"Correction: the complex genetics of gait speed: genome-wide meta-analysis approach","author":"Ben-Avraham","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bone.2017.09.008_bb0205","first-page":"8","article-title":"Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness","author":"Willems","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0210","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41467-017-00031-7","article-title":"Large meta-analysis of genome-wide association studies identifies five loci for lean body mass","volume":"8","author":"Zillikens","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.bone.2017.09.008_bb0215","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.nutres.2015.09.003","article-title":"Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999\u20132004","volume":"35","author":"Batsis","year":"2015","journal-title":"Nutr. Res."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0220","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/ageing\/afu115","article-title":"Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS)","volume":"43","author":"Cruz-Jentoft","year":"2014","journal-title":"Age Ageing"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/gerona\/glv108","article-title":"Prevalence and factors associated with sarcopenia in suburb-dwelling older chinese using the Asian Working Group for sarcopenia definition","volume":"71","author":"Han","year":"2016","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2017.09.008_bb0230","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/ggi.12193","article-title":"Epidemiology of sarcopenia among community-dwelling older adults in Taiwan: a pooled analysis for a broader adoption of sarcopenia assessments","volume":"14","author":"Wu","year":"2014","journal-title":"Geriatr Gerontol Int"},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0235","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1532-5415.2000.tb04719.x","article-title":"Epidemiology of sarcopenia","volume":"48","author":"Melton","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0240","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00391-015-0886-z","article-title":"Prevalence and definition of sarcopenia in community dwelling older people. Data from the Berlin aging study II (BASE-II)","volume":"49","author":"Spira","year":"2016","journal-title":"Z. Gerontol. Geriatr."},{"issue":"7","key":"10.1016\/j.bone.2017.09.008_bb0245","doi-asserted-by":"crossref","first-page":"528e1","DOI":"10.1016\/j.jamda.2013.03.019","article-title":"Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study","volume":"14","author":"Lee","year":"2013","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.archger.2014.08.010","article-title":"Differences in body composition and physical functions associated with sarcopenia in Chinese elderly: reference values and prevalence","volume":"60","author":"Zeng","year":"2015","journal-title":"Arch. Gerontol. Geriatr."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11357-015-9860-3","article-title":"Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults","volume":"37","author":"Tay","year":"2015","journal-title":"Age (Dordr.)"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0260","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00198-013-2455-x","article-title":"Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the Sao Paulo Ageing & Health Study (SPAH)","volume":"25","author":"Figueiredo","year":"2014","journal-title":"Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.bone.2017.09.008_bb0265","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glw343","article-title":"Prevalence and clinical correlates of sarcopenia, identified according to the EWGSOP definition and diagnostic algorithm, in hospitalized older people: the GLISTEN study","author":"Bianchi","year":"2017","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0270","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.maturitas.2015.08.006","article-title":"Prevalence and risk factors of sarcopenia among adults living in nursing homes","volume":"82","author":"Senior","year":"2015","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0275","first-page":"23","article-title":"Prevalence of pre-sarcopenia and sarcopenia in Hong Kong Chinese geriatric patients with hip fracture and its correlation with different factors","volume":"22","author":"Ho","year":"2016","journal-title":"Hong Kong Medical Journal=Xianggang yi xue za zhi"},{"key":"10.1016\/j.bone.2017.09.008_bb0280","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2147\/CIA.S89585","article-title":"Prevalence of sarcopenia in Germany and the corresponding effect of osteoarthritis in females 70years and older living in the community: results of the FORMoSA study","volume":"10","author":"Kemmler","year":"2015","journal-title":"Clin. Interv. Aging"},{"issue":"8","key":"10.1016\/j.bone.2017.09.008_bb0285","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am. J. Epidemiol."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2017.09.008_bb0290","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/ggi.12723","article-title":"Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults","volume":"16","author":"Kim","year":"2016","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0295","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/gerona\/glr035","article-title":"Prevalence and risk factors of sarcopenia among nursing home older residents","volume":"67","author":"Landi","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0300","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","article-title":"Sarcopenia: alternative definitions and associations with lower extremity function","volume":"51","author":"Newman","year":"2003","journal-title":"J. Am. Geriatr. Soc."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0305","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","article-title":"Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability","volume":"50","author":"Janssen","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0310","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0749-3797(03)00197-1","article-title":"Sarcopenia in elderly men and women: the Rancho Bernardo study","volume":"25","author":"Castillo","year":"2003","journal-title":"Am. J. Prev. Med."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0315","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"P. European Working Group on Sarcopenia in Older, Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0320","first-page":"1029","article-title":"Assessment of human body composition using dual-energy X-ray absorptiometry and bioelectrical impedance analysis","volume":"7","author":"Bolanowski","year":"2001","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0325","first-page":"45","article-title":"Comparison of body composition by bioelectrical impedance analysis and dual-energy X-ray absorptiometry in Hispanic diabetics","volume":"8","author":"Beeson","year":"2010","journal-title":"Int. J. Body Compos. Res."},{"key":"10.1016\/j.bone.2017.09.008_bb0330","doi-asserted-by":"crossref","first-page":"953060","DOI":"10.1155\/2012\/953060","article-title":"Bioelectrical impedance and dual-energy X-ray absorptiometry assessments of changes in body composition following exercise in patients with type 2 diabetes mellitus","volume":"2012","author":"Miyatani","year":"2012","journal-title":"J. Obes."},{"key":"10.1016\/j.bone.2017.09.008_bb0335","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.2000.tb06440.x","article-title":"Assessing regional muscle mass with segmental measurements of bioelectrical impedance in obese women during weight loss","volume":"904","author":"Lukaski","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0340","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1017\/S0029665115000129","article-title":"Skeletal muscle mass and quality: evolution of modern measurement concepts in the context of sarcopenia","volume":"74","author":"Heymsfield","year":"2015","journal-title":"Proc. Nutr. Soc."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0345","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ajcn\/81.1.74","article-title":"Comparison of multifrequency bioelectrical impedance analysis with dual-energy X-ray absorptiometry for assessment of percentage body fat in a large, healthy population","volume":"81","author":"Sun","year":"2005","journal-title":"Am. J. Clin. Nutr."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0350","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0355","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\"","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0360","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia","volume":"15","author":"Chen","year":"2014","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0365","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00223-013-9757-z","article-title":"Tools in the assessment of sarcopenia","volume":"93","author":"Cooper","year":"2013","journal-title":"Calcif. Tissue Int."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0370","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/gerona\/glu010","article-title":"The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates","volume":"69","author":"Studenski","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0375","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/gerona\/glu013","article-title":"An evidence-based comparison of operational criteria for the presence of sarcopenia","volume":"69","author":"Dam","year":"2014","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0380","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","article-title":"Osteoporosis prevention, diagnosis, and therapy","volume":"285","author":"Nih Consensus Development Panel on Osteoporosis Prevention, Therapy","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2017.09.008_bb0385","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arr.2015.03.002","article-title":"Muscle and bone, two interconnected tissues","volume":"21","author":"Tagliaferri","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0390","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1359\/jbmr.080218","article-title":"Genetics of the musculoskeletal system: a pleiotropic approach","volume":"23","author":"Karasik","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0395","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/jbmr.071033","article-title":"Bivariate whole genome linkage analyses for total body lean mass and BMD","volume":"23","author":"Wang","year":"2008","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0400","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1359\/jbmr.070303","article-title":"Bivariate whole genome linkage analysis for femoral neck geometric parameters and total body lean mass","volume":"22","author":"Deng","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.09.008_bb0405","doi-asserted-by":"crossref","DOI":"10.1007\/s00198-017-4151-8","article-title":"Osteosarcopenia: where bone, muscle, and fat collide","author":"Hirschfeld","year":"2017","journal-title":"Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0410","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jamda.2014.10.018","article-title":"Phenotype of osteosarcopenia in older individuals with a history of falling","volume":"16","author":"Huo","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0415","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/jcb.25040","article-title":"Interactions between muscle tissues and bone metabolism","volume":"116","author":"Kawao","year":"2015","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0420","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40520-015-0494-1","article-title":"Osteosarcopenia is more than sarcopenia and osteopenia alone","volume":"28","author":"Drey","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0425","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s12603-014-0543-z","article-title":"Comprehensive nutritional status in sarco-osteoporotic older fallers","volume":"19","author":"Huo","year":"2015","journal-title":"J. Nutr. Health Aging"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0430","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bone.2007.12.002","article-title":"Pelvic body composition measurements by quantitative computed tomography: association with recent hip fracture","volume":"42","author":"Lang","year":"2008","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0435","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jocd.2009.06.004","article-title":"Beyond FRAX: it's time to consider \"sarco-osteopenia\"","volume":"12","author":"Binkley","year":"2009","journal-title":"J. Clin. Densitom."},{"issue":"12","key":"10.1016\/j.bone.2017.09.008_bb0440","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1007\/s00198-013-2427-1","article-title":"What's in a name revisited: should osteoporosis and sarcopenia be considered components of \u201cdysmobility syndrome?\u201d","volume":"24","author":"Binkley","year":"2013","journal-title":"Osteoporos. Int.: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"10.1016\/j.bone.2017.09.008_bb0445","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2147\/CIA.S102961","article-title":"Dysmobility syndrome: current perspectives","volume":"12","author":"Hill","year":"2017","journal-title":"Clin. Interv. Aging"},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0450","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0455","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bone.2010.12.025","article-title":"Severe osteopenia and osteoporosis, sarcopenia, and frailty status in community-dwelling older women: results from the Women's Health and Aging Study (WHAS) II","volume":"48","author":"Frisoli","year":"2011","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0460","doi-asserted-by":"crossref","first-page":"371e7","DOI":"10.1016\/j.jamda.2016.01.013","article-title":"Common ground? The concordance of sarcopenia and frailty definitions","volume":"17","author":"Reijnierse","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0465","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cger.2011.03.007","article-title":"Sarcopenia and obesity","volume":"27","author":"Waters","year":"2011","journal-title":"Clin. Geriatr. Med."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0470","first-page":"201","article-title":"Relationship of obesity with physical activity, aerobic fitness and muscle strength in Flemish adults","volume":"48","author":"Duvigneaud","year":"2008","journal-title":"J. Sports Med. Phys. Fitness"},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0475","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/MCO.0b013e328312c37d","article-title":"Sarcopenic obesity: definition, cause and consequences","volume":"11","author":"Stenholm","year":"2008","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0480","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1046\/j.1532-5415.2002.50217.x","article-title":"Leg muscle mass and composition in relation to lower extremity performance in men and women aged 70 to 79: the health, aging and body composition study","volume":"50","author":"Visser","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0485","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3945\/ajcn.2008.26950","article-title":"Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study","volume":"89","author":"Rolland","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0490","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1046\/j.1532-5415.2002.50508.x","article-title":"Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III","volume":"50","author":"Davison","year":"2002","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0495","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/jgs.12260","article-title":"Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999\u20132004","volume":"61","author":"Batsis","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0500","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0505","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000356760","article-title":"Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review","volume":"60","author":"Ali","year":"2014","journal-title":"Gerontology"},{"key":"10.1016\/j.bone.2017.09.008_bb0510","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2015.04.003","article-title":"Cachexia and sarcopenia: mechanisms and potential targets for intervention","volume":"22","author":"Argiles","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0515","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.clnu.2012.02.007","article-title":"Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study","volume":"31","author":"Landi","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.bone.2017.09.008_bb0520","article-title":"Sarcopenia in patients scheduled to undergo orthopaedic surgery","author":"Ji","year":"2014","journal-title":"Bone"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0525","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1245\/s10434-015-4887-3","article-title":"Sarcopenia adversely impacts postoperative clinical outcomes following gastrectomy in patients with gastric cancer: a prospective study","volume":"23","author":"Wang","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0530","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.3928\/01477447-20160811-02","article-title":"Effect of Sarcopenia on Postoperative Morbidity and Mortality After Thoracolumbar Spine Surgery","volume":"39","author":"Bokshan","year":"2016","journal-title":"Orthopedics"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0535","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/SLA.0b013e31826028b1","article-title":"Analytic morphomics, core muscle size, and surgical outcomes","volume":"256","author":"Englesbe","year":"2012","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0540","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2010.03.039","article-title":"Sarcopenia and mortality after liver transplantation","volume":"211","author":"Englesbe","year":"2010","journal-title":"J. Am. Coll. Surg."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0545","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12603-012-0434-0","article-title":"Mortality as an adverse outcome of sarcopenia","volume":"17","author":"Arango-Lopera","year":"2013","journal-title":"J. Nutr. Health Aging"},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0550","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jamcollsurg.2013.04.042","article-title":"Cost of major surgery in the sarcopenic patient","volume":"217","author":"Sheetz","year":"2013","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0555","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1532-5415.2011.03776.x","article-title":"Effects of exercise and amino acid supplementation on body composition and physical function in community-dwelling elderly Japanese sarcopenic women: a randomized controlled trial","volume":"60","author":"Kim","year":"2012","journal-title":"J. Am. Geriatr. Soc."},{"issue":"9","key":"10.1016\/j.bone.2017.09.008_bb0560","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jamda.2015.05.021","article-title":"Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial","volume":"16","author":"Bauer","year":"2015","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0565","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jamda.2016.08.009","article-title":"Impacts of high-protein oral nutritional supplements among malnourished men and women with sarcopenia: a multicenter, randomized, double-blinded, controlled trial","volume":"17","author":"Cramer","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0570","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1210\/jc.2014-1742","article-title":"The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials","volume":"99","author":"Beaudart","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0575","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12020-013-0070-4","article-title":"Creatine supplementation and aging musculoskeletal health","volume":"45","author":"Candow","year":"2014","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0580","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1017\/S0029665115002049","article-title":"Nutritional interventions in sarcopenia: a critical review","volume":"74","author":"Hickson","year":"2015","journal-title":"Proc. Nutr. Soc."},{"issue":"12","key":"10.1016\/j.bone.2017.09.008_bb0585","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1532-5415.2004.52557.x","article-title":"Resistance training in the early postoperative phase reduces hospitalization and leads to muscle hypertrophy in elderly hip surgery patients\u2013a controlled, randomized study","volume":"52","author":"Suetta","year":"2004","journal-title":"J. Am. Geriatr. Soc."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0590","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.gerinurse.2015.11.001","article-title":"Impact of resistance training on sarcopenia in nursing care facilities: a pilot study","volume":"37","author":"Hassan","year":"2016","journal-title":"Geriatr. Nurs."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0595","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12603-013-0369-0","article-title":"The impact of sarcopenia on a physical activity intervention: the Lifestyle Interventions and Independence for Elders Pilot Study (LIFE-P)","volume":"18","author":"Liu","year":"2014","journal-title":"J. Nutr. Health Aging"},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0600","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1177\/0269215511405078","article-title":"The effects of whole body vibration therapy on bone mineral density and leg muscle strength in older adults: a systematic review and meta-analysis","volume":"25","author":"Lau","year":"2011","journal-title":"Clin. Rehabil."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0605","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0838.2010.01126.x","article-title":"Effect of whole-body vibration on neuromuscular performance and body composition for females 65 years and older: a randomized-controlled trial","volume":"22","author":"von Stengel","year":"2012","journal-title":"Scand. J. Med. Sci. Sports"},{"key":"10.1016\/j.bone.2017.09.008_bb0610","doi-asserted-by":"crossref","DOI":"10.1111\/ggi.12878","article-title":"Optimal frequency\/time combination of whole-body vibration training for improving muscle size and strength of people with age-related muscle loss (sarcopenia): A randomized controlled trial","author":"Wei","year":"2016","journal-title":"Geriatr Gerontol Int"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0615","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"5","author":"Potsch","year":"2014","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0620","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","article-title":"Muscle wasting in disease: molecular mechanisms and promising therapies","volume":"14","author":"Cohen","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0625","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0630","first-page":"611","article-title":"Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice","volume":"123","author":"Porporato","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.bone.2017.09.008_bb0635","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1210\/en.2015-1353","article-title":"Improvement of physical decline through combined effects of muscle enhancement and mitochondrial activation by a gastric hormone ghrelin in male 5\/6Nx CKD model mice","volume":"156","author":"Tamaki","year":"2015","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0640","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0645","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1210\/jc.2008-0632","article-title":"Effects of an oral growth hormone secretagogue in older adults","volume":"94","author":"White","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035708","article-title":"Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"7","author":"Miki","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0655","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0660","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2010.05.042","article-title":"Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference","volume":"144","author":"von Haehling","year":"2010","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0665","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/cs1010147","article-title":"Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study","volume":"101","author":"Sipila","year":"2001","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0670","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1042\/cs0910685","article-title":"Effects of hormone replacement therapy on muscle performance and balance in post-menopausal women","volume":"91","author":"Armstrong","year":"1996","journal-title":"Clin. Sci. (Lond.)"},{"issue":"10","key":"10.1016\/j.bone.2017.09.008_bb0675","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/gerona\/glp082","article-title":"Hormone therapy and skeletal muscle strength: a meta-analysis","volume":"64","author":"Greising","year":"2009","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0680","first-page":"109","article-title":"Benefits of estrogen replacement for skeletal muscle mass and function in post-menopausal females: evidence from human and animal studies","volume":"43","author":"Tiidus","year":"2011","journal-title":"Eur. J. Med."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0685","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1152\/japplphysiol.91518.2008","article-title":"Postmenopausal hormone replacement therapy modifies skeletal muscle composition and function: a study with monozygotic twin pairs","volume":"107","author":"Ronkainen","year":"2009","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0690","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/japplphysiol.00590.2009","article-title":"Influence of hormone replacement therapy on eccentric exercise induced myogenic gene expression in postmenopausal women","volume":"107","author":"Dieli-Conwright","year":"2009","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"24","key":"10.1016\/j.bone.2017.09.008_bb0695","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial","volume":"289","author":"Chlebowski","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2017.09.008_bb0700","first-page":"217","article-title":"Optimal management of sarcopenia","volume":"5","author":"Burton","year":"2010","journal-title":"Clin. Interv. Aging"},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0705","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1677\/joe.0.1700027","article-title":"Proof of the effect of testosterone on skeletal muscle","volume":"170","author":"Bhasin","year":"2001","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0710","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1152\/japplphysiol.00490.2009","article-title":"Testosterone represses ubiquitin ligases atrogin-1 and Murf-1 expression in an androgen-sensitive rat skeletal muscle in vivo","volume":"108","author":"Pires-Oliveira","year":"2010","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"2","key":"10.1016\/j.bone.2017.09.008_bb0715","doi-asserted-by":"crossref","first-page":"E223","DOI":"10.1210\/jc.2014-2759","article-title":"Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males","volume":"100","author":"Fitts","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0720","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/GME.0000000000000093","article-title":"Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial","volume":"21","author":"Huang","year":"2014","journal-title":"Menopause"},{"issue":"16","key":"10.1016\/j.bone.2017.09.008_bb0725","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2010.03.090","article-title":"Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study","volume":"56","author":"Iellamo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.bone.2017.09.008_bb0730","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1093\/gerona\/60.11.1451","article-title":"Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials","volume":"60","author":"Calof","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.bone.2017.09.008_bb0735","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1741-7015-11-108","article-title":"Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials","volume":"11","author":"Xu","year":"2013","journal-title":"BMC Med."},{"issue":"8","key":"10.1016\/j.bone.2017.09.008_bb0740","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1681\/ASN.2006010034","article-title":"Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial","volume":"17","author":"Johansen","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bone.2017.09.008_bb0745","unstructured":"Add-on study for protocol G200802 (NCT02463032): effect of GTx-024 on maximal neuromuscular function and lean body mass - full text view - ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02746328?term=enobosarm&rank=2>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0750","unstructured":"M.U.M. Center, The effect of nandrolone decanoate and leucine on muscle loss - tabular view - ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT02376309>, 2017)."},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0755","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13539-011-0046-2","volume":"2","author":"Stewart Coats","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0760","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mus.23539","article-title":"A single ascending-dose study of muscle regulator ACE-031 in healthy volunteers","volume":"47","author":"Attie","year":"2013","journal-title":"Muscle Nerve"},{"issue":"12","key":"10.1016\/j.bone.2017.09.008_bb0765","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","volume":"3","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0770","first-page":"62","article-title":"A Phase 2 randomized study investigating the efficacy and safety of myostatin antibody LY2495655 versus placebo in patients undergoing elective total hip arthroplasty","volume":"5","author":"Woodhouse","year":"2016","journal-title":"J. Frailty Aging"},{"key":"10.1016\/j.bone.2017.09.008_bb0775","unstructured":"A randomized, double-blind, placebo-controlled multi-center study to assess the effects of BYM338 on skeletal muscle in sarcopenic adults with mobility limitations, Last Access July 8, 2017 <https:\/\/www.novctrd.com\/CtrdWeb\/displaypdf.nov?trialresultid=13323> (2014)."},{"key":"10.1016\/j.bone.2017.09.008_bb0780","unstructured":"BYM338 in Chronic Obstructive Pulmonary Disease (COPD) patients with cachexia - full text view - ClinicalTrials.gov. <https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01669174?cond=bimagrumab&draw=1&rank=6>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0785","unstructured":"Efficacy and safety of bimagrumab\/BYM338 at 52weeks on physical function, muscle strength, mobility in sibm patients - full text view - ClinicalTrials.gov. <https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01925209?cond=bimagrumab&draw=1&rank=5>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0790","article-title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial","author":"Campbell","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bone.2017.09.008_bb0795","unstructured":"Study of efficacy and safety of bimagrumab in patients after hip fracture surgery. <https:\/\/www.novartisclinicaltrials.com\/TrialConnectWeb\/aboutresult.nov?studyid=55051>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0800","unstructured":"Clinical trial to evaluate the efficacy, safety, and tolerability of BMS-986089 in ambulatory boys with duchenne muscular dystrophy - full text view - ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03039686?term=BMS-986089&rank=1>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0805","unstructured":"A phase 2 study to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of PF-06252616 in Duchenne muscular dystrophy - full text view - ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02310763?term=PF-06252616&rank=1>, 2017)."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0810","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.cell.2012.10.050","article-title":"A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy","volume":"151","author":"Ruas","year":"2012","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0815","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mus.20416","article-title":"Phosphodiesterase 4 inhibition reduces skeletal muscle atrophy","volume":"32","author":"Hinkle","year":"2005","journal-title":"Muscle Nerve"},{"issue":"9","key":"10.1016\/j.bone.2017.09.008_bb0820","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/j.1532-5415.2008.01854.x","article-title":"Prevalence of sarcopenia estimated using a bioelectrical impedance analysis prediction equation in community-dwelling elderly people in Taiwan","volume":"56","author":"Chien","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.bone.2017.09.008_bb0825","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","article-title":"Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study","volume":"21","author":"Garcia","year":"2013","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.bone.2017.09.008_bb0830","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","article-title":"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial","volume":"149","author":"Nass","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0835","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/gerona\/60.5.648","article-title":"The effect of nandrolone decanoate on bone mineral density, muscle mass, and hemoglobin levels in elderly women with osteoporosis: a double-blind, randomized, placebo-controlled clinical trial","volume":"60","author":"Frisoli","year":"2005","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"3","key":"10.1016\/j.bone.2017.09.008_bb0840","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J. Cachex. Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.bone.2017.09.008_bb0845","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bone.2017.09.008_bb0850","unstructured":"Phase III study of the effect of GTx-024 on muscle wasting in patients with Non-small Cell Lung Cancer (NSCLC) - full text view - ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01355484?term=enobosarm&rank=9>, 2017)."},{"issue":"6","key":"10.1016\/j.bone.2017.09.008_bb0855","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12603-013-0335-x","article-title":"A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia","volume":"17","author":"Papanicolaou","year":"2013","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.bone.2017.09.008_bb0860","unstructured":"Clinical study of BYM338 for the treatment of unintentional weight loss in patients with cancer of the lung or the pancreas - full text view - ClinicalTrials.gov. <https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01433263?cond=bimagrumab&draw=1&rank=10>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0865","unstructured":"A phase 2 study of LY2495655 in participants with pancreatic cancer - full text view - ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01505530?term=LY2495655&rank=1>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0870","unstructured":"Study of the safety and efficacy of REGN1033 (SAR391786) in patients with sarcopenia - full text view - ClinicalTrials.gov. <https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01963598?term=regn1033&rank=3>, 2017)."},{"key":"10.1016\/j.bone.2017.09.008_bb0875","unstructured":"Atara bio announces results from the phase 2 proof-of-concept PINTA 745 clinical trial for protein energy wasting in patients with end stage renal disease, last access July 8, 2017 <http:\/\/investors.atarabio.com\/\/releasedetail.cfm?releaseid=946796> (2017)."},{"issue":"5","key":"10.1016\/j.bone.2017.09.008_bb0880","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.21338","article-title":"A phase I\/IItrial of MYO-029 in adult subjects with muscular dystrophy","volume":"63","author":"Wagner","year":"2008","journal-title":"Ann. Neurol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217303459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T10:09:13Z","timestamp":1539166153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217303459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":176,"alternative-id":["S8756328217303459"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.09.008","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of sarcopenia: Enhancing awareness of an increasingly prevalent disease","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}